Pancreatic Cancer Research

ResearcherUniversity of VeronaActive in the last 2 years

Stefania Forciniti

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6719-1591; OpenAlex author ID A5001389977. Sources: OpenAlex.

Their work

Papers
7 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 7

  1. The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-25-4154↗
  2. Metabolic sensing in 3D models of pancreatic ductal adenocarcinoma: probing pH, oxygen, and lactate dynamics to decode chemoresistance. First author DOI 10.3389/fbioe.2026.1926254↗
  3. A 3D Pancreatic Cancer Model with Integrated Optical Sensors for Noninvasive Metabolism Monitoring and Drug Screening. First author DOI 10.1002/adhm.202401138↗
  4. 3-Bromo-Isoxazoline Derivatives Inhibit GAPDH Enzyme in PDAC Cells Triggering Autophagy and Apoptotic Cell Death. Co-author DOI 10.3390/cancers14133153↗
  5. Extracellular Matrix Composition Modulates the Responsiveness of Differentiated and Stem Pancreatic Cancer Cells to Lipophilic Derivate of Gemcitabine. Co-author DOI 10.3390/ijms22010029↗
  6. Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes. First author DOI 10.1016/j.bbagen.2018.09.018↗
  7. Extracellular matrix composition modulates PDAC parenchymal and stem cell plasticity and behavior through the secretome. Co-author DOI 10.1111/febs.14471↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anna Chiara Siciliano · 2 shared papers, 2024–2026 · strength 0.57
  2. Loretta L. del Mercato · 2 shared papers, 2024–2026 · strength 0.57
  3. Elisa Dalla Pozza · 4 shared papers, 2018–2022 · strength 0.39
  4. Ilaria Dando · 4 shared papers, 2018–2022 · strength 0.39
  5. Marta Palmieri · 3 shared papers, 2018–2020 · strength 0.25
  6. Raffaella Pacchiana · 2 shared papers, 2020–2022 · strength 0.23
  7. Massimo Donadelli · 2 shared papers, 2020–2022 · strength 0.23
  8. Massimiliano Mazzone · 1 shared paper, 2026 · strength 0.22
  9. Federica Rubbino · 1 shared paper, 2026 · strength 0.22
  10. Claudio Doglioni · 1 shared paper, 2026 · strength 0.22
  11. Paola Cappello · 1 shared paper, 2026 · strength 0.22
  12. Luana Greco · 1 shared paper, 2026 · strength 0.22
  13. Alessandro Zerbi · 1 shared paper, 2026 · strength 0.22
  14. Luigi Laghi · 1 shared paper, 2026 · strength 0.22
  15. Francesco Novelli · 1 shared paper, 2026 · strength 0.22
  16. Massimo Falconi · 1 shared paper, 2026 · strength 0.22
  17. Enza Lonardo · 1 shared paper, 2024 · strength 0.22
  18. Donatella Delle Cave · 1 shared paper, 2024 · strength 0.22
  19. Silvia Arpicco · 2 shared papers, 2019–2020 · strength 0.18
  20. Maria Raffaella Greco · 2 shared papers, 2018–2020 · strength 0.17
  21. Stephan J. Reshkin · 2 shared papers, 2018–2020 · strength 0.17
  22. Rosa Angela Cardone · 2 shared papers, 2018–2020 · strength 0.17
  23. Paola Conti · 1 shared paper, 2022 · strength 0.14
  24. Tiago M. A. Carvalho · 1 shared paper, 2020 · strength 0.09
  25. Cristian Andres Carmona‐Carmona · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.